| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |